Your browser doesn't support javascript.
loading
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
Moore, Wendy C; Kornmann, Oliver; Humbert, Marc; Poirier, Claude; Bel, Elisabeth H; Kaneko, Norihiro; Smith, Steven G; Martin, Neil; Gilson, Martyn J; Price, Robert G; Bradford, Eric S; Liu, Mark C.
Afiliación
  • Moore WC; Dept of Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, USA wmoore@wakehealth.edu.
  • Kornmann O; IKF Pneumologie Frankfurt, Clinical Research Centre Respiratory Diseases, Frankfurt, Germany.
  • Humbert M; Université Paris-Saclay, Paris, France.
  • Poirier C; Assistance Publique- Hôpitaux de Paris, Service de Pneumologie et Soins Intensifs Respiratoires, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
  • Bel EH; INSERM U999, Le Kremlin-Bicêtre, Paris, France.
  • Kaneko N; Département de Médecine, Service de Pneumologie, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, QC, Canada.
  • Smith SG; Dept of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Martin N; Dept of Pulmonary Medicine, Kameda Medical Center, Kamogawa, Japan.
  • Gilson MJ; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA.
  • Price RG; Global Medical Affairs, GSK, Brentford, UK.
  • Bradford ES; Institute for Lung Health, University of Leicester, Leicester, UK.
  • Liu MC; Respiratory Research and Development, GSK, Uxbridge, UK.
Eur Respir J ; 59(1)2022 01.
Article en En | MEDLINE | ID: mdl-34172470
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Eur Respir J Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos